About Lyxorpro
Overview
Lyxorpro is a financial services entity registered in the United Kingdom, with a registered address at 27 Knightsbridge, London SW1X 7NP. The company was founded on 11 March 2022.
As of the time of this review, Lyxorpro is not listed with any financial regulatory authority. This absence of regulation means that the broker is not subject to oversight by bodies such as the Financial Conduct Authority (FCA) in the UK, which typically imposes strict standards for client fund protection, transparency, and operational conduct.
Background and Registration
Lyxorpro's registration details indicate it is a legally incorporated entity in the United Kingdom. However, company registration alone does not equate to financial licensing or authorization to offer regulated financial services.
The address at Knightsbridge is a well-known London location, but without regulatory status, the broker's legitimacy and operational standards remain unverified. Traders should exercise caution when dealing with unregulated firms, as there may be limited recourse in cases of dispute.
Regulatory Status
A critical factor for any forex broker is regulatory oversight. Our records show that Lyxorpro holds no licenses from any recognized financial regulator. This includes the FCA (UK), CySEC (Cyprus), or other major authorities such as ASIC (Australia) or the CFTC (USA).
Without regulation, there are no mandatory requirements for segregation of client funds, negative balance protection, or participation in compensation schemes. This significantly elevates the risk for traders.
Trading Services and Offerings
Based on the limited public information available, it is unclear what specific trading services or instruments Lyxorpro offers. There is no confirmed data on account types, platforms, leverage, or tradable assets.
The lack of transparent information on the broker's own website or through independent sources makes it difficult to assess the suitability of its services for retail or institutional traders.
Client Suitability
Given the absence of regulatory oversight and the general lack of public information, Lyxorpro is not suitable for traders who prioritize security, transparency, and regulatory protection.
The broker may be intended for a niche or undefined audience, but without clear details, it is impossible to recommend it for any specific trader profile. Potential clients should seek well-regulated alternatives.
Overview compiled by FXCanary from regulatory records and public data. full Lyxorpro review